Researchers investigated characteristics of adolescent and young adult patients with HCC and risk factors that affect survival.

Researchers sought to determine whether ZA plus a proteasome inhibitor would reduce the risk of SREs in patients with MM.

A secondary analysis of cross-sectional studies identified 3 symptom clusters commonly experienced by breast cancer survivors with and without lymphedema.

Melanoma incidence decreased for those aged 20 to 29, 30 to 39, 40 to 49 years; decline in melanoma mortality seen for those aged 30 to 59 years.

(HealthDay News) — A postoperative wearable device may improve physical activity and patient-reported dyspnea at six months after lung cancer surgery, according to a study published online Sept. 20 in ...